To further evaluate the role of PRMT5 in PAAD in vivo tumorigenesis, we knocked down the PRMT5 in KPC cell line with shRNA and established the xenograft model (Figure S7A–C). The gene discussed is PRMT5; the disease is pancreatic adenocarcinoma.